JP2009509508A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009509508A5 JP2009509508A5 JP2008532490A JP2008532490A JP2009509508A5 JP 2009509508 A5 JP2009509508 A5 JP 2009509508A5 JP 2008532490 A JP2008532490 A JP 2008532490A JP 2008532490 A JP2008532490 A JP 2008532490A JP 2009509508 A5 JP2009509508 A5 JP 2009509508A5
- Authority
- JP
- Japan
- Prior art keywords
- snp
- seq
- individual
- reagent
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003153 chemical reaction reagent Substances 0.000 claims 11
- 108020004707 nucleic acids Proteins 0.000 claims 11
- 150000007523 nucleic acids Chemical class 0.000 claims 11
- 229920000023 polynucleotide Polymers 0.000 claims 11
- 239000002157 polynucleotide Substances 0.000 claims 11
- 239000002773 nucleotide Substances 0.000 claims 8
- 125000003729 nucleotide group Chemical group 0.000 claims 8
- 239000000523 sample Substances 0.000 claims 8
- 229920001184 polypeptide Polymers 0.000 claims 6
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 5
- 230000001154 acute Effects 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 102000004965 antibodies Human genes 0.000 claims 3
- 108090001123 antibodies Proteins 0.000 claims 3
- 230000027455 binding Effects 0.000 claims 3
- 238000001514 detection method Methods 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 238000004166 bioassay Methods 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 238000005755 formation reaction Methods 0.000 claims 2
- 238000009396 hybridization Methods 0.000 claims 2
- 102000035365 modified proteins Human genes 0.000 claims 2
- 108091005569 modified proteins Proteins 0.000 claims 2
- 229920002395 Aptamer Polymers 0.000 claims 1
- 210000000601 Blood Cells Anatomy 0.000 claims 1
- 208000008787 Cardiovascular Disease Diseases 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 208000010125 Myocardial Infarction Diseases 0.000 claims 1
- 101700080605 NUC1 Proteins 0.000 claims 1
- 229920000272 Oligonucleotide Polymers 0.000 claims 1
- 230000003321 amplification Effects 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- 230000000295 complement Effects 0.000 claims 1
- 239000002872 contrast media Substances 0.000 claims 1
- 230000029087 digestion Effects 0.000 claims 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 101700006494 nucA Proteins 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
Claims (25)
- 急性冠状動脈事象を発症する変更された危険性を有する個体を同定するのを支援する方法、またはスタチン処置に応答する個体の可能性を評価するのを支援する方法であって、該方法が、
該個体の核酸のサンプルにおけるSNPの対立遺伝子の存在または非存在を検出する工程
を包含し、ここで該SNPは、配列番号263の101位によって示され、そして該対立遺伝子の存在または非存在は、急性冠状動脈事象を発症する個体の危険性またはスタチン処置に応答する可能性に相関する、方法。 - 前記個体の核酸と検出試薬とを接触させる工程、およびどのヌクレオチドが、特定されたSNP位置に存在するかまたは存在しないかを決定する工程を包含する、請求項1に記載の方法。
- 前記核酸は、前記個体の血液細胞から調製される、請求項2に記載の方法。
- 前記検出試薬は、ポリヌクレオチドプローブである、請求項2に記載の方法。
- 前記プローブの3’末端は、前記核酸におけるSNPにハイブリダイズする、請求項4に記載の方法。
- 前記プローブは、レポーター色素によって標識される、請求項4に記載の方法。
- 核酸分子における配列番号263の101位によって示される一塩基多型(SNP)を検出する方法であって、
試験サンプルと、ストリンジェントなハイブリダイゼーション条件下で配列番号263のヌクレオチド配列におけるSNPに特異的にハイブリダイズする試薬とを接触させる工程、ならびに
ハイブリダイズした二重鎖の形成を検出する工程
を包含する、方法。 - 前記検出は、対立遺伝子特異的プローブハイブリダイゼーション、対立遺伝子特異的プライマー伸長、対立遺伝子特異的増幅、配列決定、5’ヌクレアーゼ消化、分子ビーコンアッセイ、オリゴヌクレオチドライゲーションアッセイ、サイズ分析、および一本鎖立体配座多型からなる群より選択される工程によって行なわれる、請求項7に記載の方法。
- 急性冠状動脈事象を発症する変更された危険性を有する個体を同定するのを支援する方法、またはスタチン処置に応答する個体の可能性を評価するのを支援する方法であって、該方法が、
該個体の核酸のサンプルにおける多型の存在または非存在を検出する工程
を包含し、該多型は、配列番号263のヌクレオチド配列における101位によって示されるSNPとの連鎖不均衡に存在し、そして該多型の存在または非存在は、急性冠状動脈事象を発症する個体の危険性またはスタチン処置に応答する可能性に相関する、方法。 - 個体において心臓血管障害を処置する方法であって、該方法が、
配列番号263の101位によって示されるSNPの存在または非存在によって予測されるようなスタチン処置に応答する該個体の可能性に基づいて有効な量のスタチン
を含む
、方法。 - SNP含有核酸分子によってコードされる改変タンパク質を検出するための試薬であって、該試薬は、別の核酸分子によってコードされるタンパク質と比較して、該改変タンパク質に選択的に結合し、ここで該SNP含有核酸分子は、配列番号263の配列番号101によって示されるSNPを含む、試薬。
- 前記試薬は、抗体、抗体フラグメント、アプタマー、ペプチド、リガンドまたは低分子化合物である、請求項11に記載の試薬。
- 前記試薬は、レポーター色素または造影剤によって標識される、請求項12に記載の試薬。
- 請求項11に記載の試薬および緩衝液を備える、キット。
- 増幅されたポリヌクレオチドであって、該増幅されたポリヌクレオチドが、配列番号263またはその相補体の101位によって示される一塩基多型(SNP)を含み、ここで、該増幅されたポリヌクレオチドが、約16ヌクレオチドと約1,000ヌクレオチドとの間の長さである、増幅されたポリヌクレオチド。
- 前記ヌクレオチド配列は、配列番号263のヌクレオチド配列を含む、請求項15に記載の増幅されたポリヌクレオチド。
- 配列番号263のヌクレオチド配列における101位によって示される一塩基多型(SNP)を含む核酸分子に特異的にハイブリダイズする、単離されたポリヌクレオチド。
- 8ヌクレオチド〜70ヌクレオチドの長さである、請求項17に記載のポリヌクレオチド。
- 対立遺伝子特異的プローブである、請求項17に記載のポリヌクレオチド。
- 対立遺伝子特異的プライマーである、請求項17に記載のポリヌクレオチド。
- 核酸における一塩基多型(SNP)を検出するためのキットであって、請求項17に記載のポリヌクレオチド、緩衝液、および酵素を備える、キット。
- 配列番号263からなるアミノ酸配列を含む、単離されたポリペプチド。
- 前記ポリペプチドは、配列番号263からなるアミノ酸配列を有する、請求項22に記載の単離されたポリペプチド。
- 請求項22に記載のポリペプチドに選択的に結合する、抗体。
- 心筋梗塞を治療的もしくは予防的に処置するのに有用な薬剤を同定するための方法であって、該方法が、候補薬剤に請求項24に記載のポリペプチドを、該ポリペプチドと該候補薬剤との間に結合複合体を形成させるために適切な条件下で接触させる工程、ならびに該結合複合体の形成を検出する工程を包含し、ここで、該複合体の存在が、該薬剤を同定する、方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72027405P | 2005-09-23 | 2005-09-23 | |
US60/720,274 | 2005-09-23 | ||
US11/526,137 | 2006-09-22 | ||
US11/526,137 US7799530B2 (en) | 2005-09-23 | 2006-09-22 | Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof |
PCT/US2006/037362 WO2007035953A2 (en) | 2005-09-23 | 2006-09-25 | Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009221658A Division JP2010046069A (ja) | 2005-09-23 | 2009-09-25 | 心臓血管障害および薬物応答に関連する遺伝的多型、その検出方法および使用 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2009509508A JP2009509508A (ja) | 2009-03-12 |
JP2009509508A5 true JP2009509508A5 (ja) | 2009-11-12 |
JP5111380B2 JP5111380B2 (ja) | 2013-01-09 |
Family
ID=37889578
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008532490A Active JP5111380B2 (ja) | 2005-09-23 | 2006-09-25 | 心臓血管障害および薬物応答に関連する遺伝的多型、その検出方法および使用 |
JP2009221658A Withdrawn JP2010046069A (ja) | 2005-09-23 | 2009-09-25 | 心臓血管障害および薬物応答に関連する遺伝的多型、その検出方法および使用 |
JP2013002486A Pending JP2013135671A (ja) | 2005-09-23 | 2013-01-10 | 心臓血管障害および薬物応答に関連する遺伝的多型、その検出方法および使用 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009221658A Withdrawn JP2010046069A (ja) | 2005-09-23 | 2009-09-25 | 心臓血管障害および薬物応答に関連する遺伝的多型、その検出方法および使用 |
JP2013002486A Pending JP2013135671A (ja) | 2005-09-23 | 2013-01-10 | 心臓血管障害および薬物応答に関連する遺伝的多型、その検出方法および使用 |
Country Status (5)
Country | Link |
---|---|
US (6) | US7799530B2 (ja) |
EP (3) | EP1926491B1 (ja) |
JP (3) | JP5111380B2 (ja) |
CA (1) | CA2613521C (ja) |
WO (1) | WO2007035953A2 (ja) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080233582A1 (en) * | 2005-07-26 | 2008-09-25 | Siemens Healthcare Diagnostics Inc. | Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease |
EP2021514A2 (en) | 2006-05-10 | 2009-02-11 | Dxterity Diagnostics | Detection of nucleic acid targets using chemically reactive oligonucleotide probes |
WO2008048982A2 (en) * | 2006-10-17 | 2008-04-24 | Yeda Research & Development Co. Ltd. | Method for obtaining spatial images through mri and processing the resulting spatial images and product |
US7695916B2 (en) | 2007-03-22 | 2010-04-13 | Celera Corporation | Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof |
ES2542967T3 (es) | 2007-03-29 | 2015-08-13 | Vanda Pharmaceuticals Inc. | Método de predecir una predisposición a la prolongación de QT |
US20150259747A1 (en) | 2007-03-29 | 2015-09-17 | Vanda Pharmaceuticals Inc. | Method of predicting a predisposition to qt prolongation |
US7883851B2 (en) * | 2007-05-02 | 2011-02-08 | Board Of Regents, The University Of Texas System | Common allele on chromosome 9 associated with coronary heart disease |
US20090024329A1 (en) * | 2007-07-19 | 2009-01-22 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems relating to epigenetic information |
US20090024333A1 (en) * | 2007-07-19 | 2009-01-22 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems relating to mitochondrial DNA phenotypes |
US20090022666A1 (en) * | 2007-07-19 | 2009-01-22 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems relating to mitochondrial DNA information |
US20090024330A1 (en) * | 2007-07-19 | 2009-01-22 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems relating to epigenetic phenotypes |
WO2009061734A1 (en) * | 2007-11-05 | 2009-05-14 | The Government Of The United States Of America As Represented By The Secretary Of The Deparment Of Health And Human Services | Identification of subjects likely to benefit from statin therapy |
US20090221620A1 (en) * | 2008-02-20 | 2009-09-03 | Celera Corporation | Gentic polymorphisms associated with stroke, methods of detection and uses thereof |
US20100081861A1 (en) * | 2008-04-24 | 2010-04-01 | Searete Llc | Computational System and Method for Memory Modification |
US9026369B2 (en) * | 2008-04-24 | 2015-05-05 | The Invention Science Fund I, Llc | Methods and systems for presenting a combination treatment |
US20090312595A1 (en) * | 2008-04-24 | 2009-12-17 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | System and method for memory modification |
US20090312668A1 (en) * | 2008-04-24 | 2009-12-17 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US8930208B2 (en) * | 2008-04-24 | 2015-01-06 | The Invention Science Fund I, Llc | Methods and systems for detecting a bioactive agent effect |
US20100041964A1 (en) * | 2008-04-24 | 2010-02-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring and modifying a combination treatment |
US9449150B2 (en) * | 2008-04-24 | 2016-09-20 | The Invention Science Fund I, Llc | Combination treatment selection methods and systems |
US20100125561A1 (en) * | 2008-04-24 | 2010-05-20 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US9282927B2 (en) * | 2008-04-24 | 2016-03-15 | Invention Science Fund I, Llc | Methods and systems for modifying bioactive agent use |
US8876688B2 (en) * | 2008-04-24 | 2014-11-04 | The Invention Science Fund I, Llc | Combination treatment modification methods and systems |
US20090270694A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring and modifying a combination treatment |
US20100022820A1 (en) * | 2008-04-24 | 2010-01-28 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US9560967B2 (en) * | 2008-04-24 | 2017-02-07 | The Invention Science Fund I Llc | Systems and apparatus for measuring a bioactive agent effect |
US9649469B2 (en) | 2008-04-24 | 2017-05-16 | The Invention Science Fund I Llc | Methods and systems for presenting a combination treatment |
US20100100036A1 (en) * | 2008-04-24 | 2010-04-22 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational System and Method for Memory Modification |
US9064036B2 (en) * | 2008-04-24 | 2015-06-23 | The Invention Science Fund I, Llc | Methods and systems for monitoring bioactive agent use |
US20090271375A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Combination treatment selection methods and systems |
US20090270688A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting a combination treatment |
US20100130811A1 (en) * | 2008-04-24 | 2010-05-27 | Searete Llc | Computational system and method for memory modification |
US20090271347A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring bioactive agent use |
US20100063368A1 (en) * | 2008-04-24 | 2010-03-11 | Searete Llc, A Limited Liability Corporation | Computational system and method for memory modification |
US20100017001A1 (en) * | 2008-04-24 | 2010-01-21 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US9239906B2 (en) * | 2008-04-24 | 2016-01-19 | The Invention Science Fund I, Llc | Combination treatment selection methods and systems |
US20100069724A1 (en) * | 2008-04-24 | 2010-03-18 | Searete Llc | Computational system and method for memory modification |
US20100004762A1 (en) * | 2008-04-24 | 2010-01-07 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US20090269329A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Combination Therapeutic products and systems |
US20090271122A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring and modifying a combination treatment |
US20100280332A1 (en) * | 2008-04-24 | 2010-11-04 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for monitoring bioactive agent use |
US9662391B2 (en) | 2008-04-24 | 2017-05-30 | The Invention Science Fund I Llc | Side effect ameliorating combination therapeutic products and systems |
US20100041958A1 (en) * | 2008-04-24 | 2010-02-18 | Searete Llc | Computational system and method for memory modification |
US20100015583A1 (en) * | 2008-04-24 | 2010-01-21 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational System and method for memory modification |
US20090271009A1 (en) * | 2008-04-24 | 2009-10-29 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Combination treatment modification methods and systems |
EP3093351B1 (en) * | 2008-07-09 | 2018-04-18 | Celera Corporation | Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof |
DK2414544T3 (da) | 2009-04-01 | 2014-06-16 | Dxterity Diagnostics Inc | Probe-amplifikations-afhængig kemisk ligering |
EP2322656A1 (en) * | 2009-11-17 | 2011-05-18 | Centre National de la Recherche Scientifique (C.N.R.S) | Methods for diagnosing skin diseases |
US20110269735A1 (en) * | 2010-04-19 | 2011-11-03 | Celera Corporation | Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof |
US9072713B2 (en) * | 2010-07-01 | 2015-07-07 | The Texas A&M University System | Perlecan domain V protects, repairs and restores ischemic brain stroke injury and motor function |
US20120108651A1 (en) * | 2010-11-02 | 2012-05-03 | Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) | Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof |
EP2710145B1 (en) | 2011-05-17 | 2015-12-09 | Dxterity Diagnostics Incorporated | Methods and compositions for detecting target nucleic acids |
US20130317006A1 (en) | 2012-05-24 | 2013-11-28 | Amy Yasko | Use of polymorphisms for identifying individuals at risk of developing autism |
WO2015081052A1 (en) | 2013-11-27 | 2015-06-04 | Yasko Amy | Use of polymorphisms for identifying individuals at risk of developing autism |
EP3166597A2 (en) | 2014-07-11 | 2017-05-17 | Azanta Danmark A/S | Misoprostol dispersible tablet |
DK2965750T3 (en) | 2014-07-11 | 2017-10-16 | Azanta Danmark As | Misoprostol dispersible tablet |
US9736219B2 (en) | 2015-06-26 | 2017-08-15 | Bank Of America Corporation | Managing open shares in an enterprise computing environment |
KR102260319B1 (ko) * | 2018-12-03 | 2021-06-04 | 국립암센터 | Rarres1 유전자 넉아웃 동물 모델 및 그의 제조방법 |
EP3935581A4 (en) | 2019-03-04 | 2022-11-30 | Iocurrents, Inc. | DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING |
CN110964802B (zh) * | 2019-11-11 | 2023-05-02 | 广东省中医院(广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院) | ApoE基因在脑出血急性期血肿再扩大及预后评估中的应用 |
CA3161620A1 (en) * | 2019-11-15 | 2021-05-20 | Institut De Cardiologie De Montreal | Methods for using low-dose colchicine after myocardial infarction |
Family Cites Families (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4107288A (en) | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
US4873191A (en) | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
US4870009A (en) | 1982-11-22 | 1989-09-26 | The Salk Institute For Biological Studies | Method of obtaining gene product through the generation of transgenic animals |
FR2540122B1 (fr) | 1983-01-27 | 1985-11-29 | Centre Nat Rech Scient | Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application |
GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4736866A (en) | 1984-06-22 | 1988-04-12 | President And Fellows Of Harvard College | Transgenic non-human mammals |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
NO870613L (no) | 1986-03-05 | 1987-09-07 | Molecular Diagnostics Inc | Deteksjon av mikroorganismer i en prve inneholdende nukleinsyre. |
US5004565A (en) | 1986-07-17 | 1991-04-02 | The Board Of Governors Of Wayne State University | Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5541308A (en) * | 1986-11-24 | 1996-07-30 | Gen-Probe Incorporated | Nucleic acid probes for detection and/or quantitation of non-viral organisms |
US5637677A (en) | 1987-07-16 | 1997-06-10 | The Trustees Of The University Of Pennsylvania | Biologically active compounds and methods of constructing and using the same |
US5080891A (en) | 1987-08-03 | 1992-01-14 | Ddi Pharmaceuticals, Inc. | Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
US5856522A (en) | 1995-05-04 | 1999-01-05 | Tropix, Inc. | Method of using synthesis of 1,2-dioxetanes and kits therefore |
US4988617A (en) | 1988-03-25 | 1991-01-29 | California Institute Of Technology | Method of detecting a nucleotide change in nucleic acids |
JP2897959B2 (ja) | 1988-05-20 | 1999-05-31 | エフ.ホフマン―ラ ロシュ アクチェンゲゼルシャフト | 固定化された配列特異的プローブ |
US4988167A (en) | 1988-08-10 | 1991-01-29 | Fergason James L | Light blocking and vision restoration apparatus with glint control |
US5118801A (en) | 1988-09-30 | 1992-06-02 | The Public Health Research Institute | Nucleic acid process containing improved molecular switch |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
CA2020958C (en) | 1989-07-11 | 2005-01-11 | Daniel L. Kacian | Nucleic acid sequence amplification methods |
US5494810A (en) | 1990-05-03 | 1996-02-27 | Cornell Research Foundation, Inc. | Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease |
US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
US5994073A (en) | 1990-08-30 | 1999-11-30 | Tropix, Inc. | Enhancement of chemiluminescent assays |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
US5539082A (en) | 1993-04-26 | 1996-07-23 | Nielsen; Peter E. | Peptide nucleic acids |
US5714331A (en) | 1991-05-24 | 1998-02-03 | Buchardt, Deceased; Ole | Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
US5270184A (en) | 1991-11-19 | 1993-12-14 | Becton, Dickinson And Company | Nucleic acid target generation |
DE69329800D1 (de) | 1992-04-27 | 2001-02-01 | Dartmouth College | Detektion von gensequenzen in biologischen flüssigkeiten |
DE69333969T2 (de) | 1992-10-30 | 2006-09-14 | The General Hospital Corp., Boston | Wechselwirkendes Fallensystem zur Isolierung von Proteinen |
DE69433811T2 (de) | 1993-01-07 | 2005-06-23 | Sequenom, Inc., San Diego | Dns - sequenzierung durch massenspektronomie |
US5422252A (en) | 1993-06-04 | 1995-06-06 | Becton, Dickinson And Company | Simultaneous amplification of multiple targets |
US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
US6027923A (en) | 1993-07-23 | 2000-02-22 | Bio-Rad Laboratories, Inc. | Linked linear amplification of nucleic acids |
US5527675A (en) | 1993-08-20 | 1996-06-18 | Millipore Corporation | Method for degradation and sequencing of polymers which sequentially eliminate terminal residues |
US5498531A (en) | 1993-09-10 | 1996-03-12 | President And Fellows Of Harvard College | Intron-mediated recombinant techniques and reagents |
DE4331012A1 (de) | 1993-09-13 | 1995-03-16 | Bayer Ag | Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik |
EP0730663B1 (en) | 1993-10-26 | 2003-09-24 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
US5538848A (en) | 1994-11-16 | 1996-07-23 | Applied Biosystems Division, Perkin-Elmer Corp. | Method for detecting nucleic acid amplification using self-quenching fluorescence probe |
US6015880A (en) | 1994-03-16 | 2000-01-18 | California Institute Of Technology | Method and substrate for performing multiple sequential reactions on a matrix |
US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
US5705333A (en) | 1994-08-05 | 1998-01-06 | The Regents Of The University Of California | Peptide-based nucleic acid mimics(PENAMS) |
US5773628A (en) | 1994-11-14 | 1998-06-30 | Tropix, Inc. | 1,2-dioxetane compounds with haloalkoxy groups, methods preparation and use |
US5591591A (en) | 1995-02-09 | 1997-01-07 | Tropix, Inc. | Dioxetane compounds for the chemiluminescent detection of proteases, methods of use and kits therefore |
US5589136A (en) | 1995-06-20 | 1996-12-31 | Regents Of The University Of California | Silicon-based sleeve devices for chemical reactions |
GB9517780D0 (en) | 1995-08-31 | 1995-11-01 | Roslin Inst Edinburgh | Biological manipulation |
GB9517779D0 (en) | 1995-08-31 | 1995-11-01 | Roslin Inst Edinburgh | Biological manipulation |
US5801115A (en) | 1995-09-05 | 1998-09-01 | Kataleuna Gmbh | Catalyst composition and methods for using and preparing same |
US5679803A (en) | 1995-10-25 | 1997-10-21 | Tropix, Inc. | 1,2 chemiluminescent dioxetanes of improved performance |
EP0920440B1 (en) | 1996-02-09 | 2012-08-22 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
US5885470A (en) | 1997-04-14 | 1999-03-23 | Caliper Technologies Corporation | Controlled fluid transport in microfabricated polymeric substrates |
JP2000508912A (ja) | 1996-04-19 | 2000-07-18 | スペクトラ バイオメディカル,インコーポレイテッド | 多型形態と複数の表現型との相関付け |
EP2369007B1 (en) | 1996-05-29 | 2015-07-29 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
US6117635A (en) | 1996-07-16 | 2000-09-12 | Intergen Company | Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon |
US5866336A (en) | 1996-07-16 | 1999-02-02 | Oncor, Inc. | Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon |
US5800999A (en) | 1996-12-16 | 1998-09-01 | Tropix, Inc. | Dioxetane-precursor-labeled probes and detection assays employing the same |
AU727083B2 (en) | 1997-04-25 | 2000-11-30 | Caliper Life Sciences, Inc. | Microfluidic devices incorporating improved channel geometries |
US6119096A (en) | 1997-07-31 | 2000-09-12 | Eyeticket Corporation | System and method for aircraft passenger check-in and boarding using iris recognition |
US6506594B1 (en) | 1999-03-19 | 2003-01-14 | Cornell Res Foundation Inc | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
US6453244B1 (en) * | 2000-02-10 | 2002-09-17 | Stanford University | Detection of polymorphisms by denaturing high-performance liquid chromatography |
US6346410B1 (en) * | 2000-08-11 | 2002-02-12 | Cytokinetics, Inc. | Motor proteins and methods for their use |
USH2191H1 (en) * | 2000-10-24 | 2007-06-05 | Snp Consortium | Identification and mapping of single nucleotide polymorphisms in the human genome |
WO2002072889A2 (en) | 2001-01-12 | 2002-09-19 | Applera Corporation | Methods and compositions for microarray control |
US6492155B2 (en) * | 2001-03-09 | 2002-12-10 | Applera Corporation | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
CA2474482A1 (en) * | 2002-01-25 | 2003-08-07 | Applera Corporation | Methods for placing, accepting, and filling orders for products and services |
WO2004058990A2 (en) * | 2002-12-20 | 2004-07-15 | Applera Corporation | Genetic polymorphisms associated with stenosis, methods of detection and uses thereof |
US20040210400A1 (en) * | 2003-01-27 | 2004-10-21 | Perlegen Sciences, Inc. | Analysis methods for individual genotyping |
CA2514950A1 (en) | 2003-01-30 | 2004-08-12 | Applera Corporation | Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof |
CA3050151C (en) | 2003-11-26 | 2023-03-07 | Celera Corporation | Single nucleotide polymorphisms associated with cardiovascular disorders and statin response, methods of detection and uses thereof |
CA2555259A1 (en) | 2004-02-27 | 2005-09-09 | Applera Corporation | Genetic polymorphisms associated with stroke, methods of detection and uses thereof |
WO2005087953A2 (en) | 2004-03-05 | 2005-09-22 | Applera Corporation | Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof |
US7695916B2 (en) * | 2007-03-22 | 2010-04-13 | Celera Corporation | Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof |
-
2006
- 2006-09-22 US US11/526,137 patent/US7799530B2/en active Active
- 2006-09-25 WO PCT/US2006/037362 patent/WO2007035953A2/en active Application Filing
- 2006-09-25 CA CA2613521A patent/CA2613521C/en active Active
- 2006-09-25 JP JP2008532490A patent/JP5111380B2/ja active Active
- 2006-09-25 EP EP06815404A patent/EP1926491B1/en active Active
- 2006-09-25 EP EP20110188240 patent/EP2471953B1/en active Active
- 2006-09-25 EP EP11188231.2A patent/EP2471952B1/en active Active
-
2009
- 2009-09-25 JP JP2009221658A patent/JP2010046069A/ja not_active Withdrawn
-
2010
- 2010-04-12 US US12/758,663 patent/US20100261187A1/en not_active Abandoned
-
2013
- 2013-01-10 JP JP2013002486A patent/JP2013135671A/ja active Pending
-
2014
- 2014-09-08 US US14/479,916 patent/US20150111775A1/en not_active Abandoned
-
2016
- 2016-01-14 US US14/995,490 patent/US20160265055A1/en not_active Abandoned
-
2018
- 2018-03-26 US US15/935,506 patent/US20190292598A1/en not_active Abandoned
-
2021
- 2021-01-04 US US17/140,716 patent/US20210348232A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009509508A5 (ja) | ||
JP2009523005A5 (ja) | ||
JP2009519703A5 (ja) | ||
JP2009521905A5 (ja) | ||
JP2009519001A5 (ja) | ||
JP2014533949A5 (ja) | ||
WO2001042498A1 (fr) | Procede de detection de polymorphisme nucleotidique | |
JP2012503985A5 (ja) | ||
JP2009523006A5 (ja) | ||
US11046999B2 (en) | Methods and compositions for genomic target enrichment and selective DNA sequencing | |
US9932638B2 (en) | Single nucleotide polymorphism in HLA-B*15:02 and use thereof | |
JP2006521812A5 (ja) | ||
JP2013074888A (ja) | IL28B(rs8099917)とITPA(rs1127354)の変異を検出する方法 | |
JP4228041B2 (ja) | 塩基多型の検出方法 | |
US20120172239A1 (en) | Method for the identification by molecular techniques of genetic variants that encode no d antigen (d-) and altered c antigen (c+w) | |
JP2008079604A (ja) | アルコール分解能と宿酔の耐性とを予測するためのプライマーセット、プローブセット、方法及びキット | |
JP2004528032A5 (ja) | ||
US11225684B2 (en) | Method and device for SNP genotyping | |
WO2006064745A1 (ja) | 塩基多型の同定方法 | |
JP3656952B2 (ja) | 慢性関節リウマチ患者における続発性aa−アミロイドーシス罹患危険率の検出方法及びsaa1遺伝子座における一塩基多型を含む新規オリゴヌクレオチド | |
KR100790871B1 (ko) | 심근 경색에 관련된 유전자 다형성 및 그의 용도 | |
Ginya et al. | Development of the Handy Bio-Strand and its application to genotyping of OPRM1 (A118G) | |
Galbiati et al. | Development of new substrates for high‐sensitive genotyping of minority mutated alleles | |
US20030022175A1 (en) | Diagnostic assay of genetic mutations by discriminating amplification and hybridization | |
JP4825956B2 (ja) | 気道粘膜炎症性疾患の罹患リスクの判定 |